Overview

Stable Isotope Labeled Compounds Market is poised to value over USD 325.2 million by 2027 end at a CAGR of over 2.9% during the forecast period 2020 to 2027

The burgeoning in the reseach of proteomics, rising research and development-related acitivities in teh biotechnology and pharmaceutical sector and growing incidnces of cancer are some key factors accountable for the growth of the market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Stable Isotope Labeled Compounds Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of Stable Isotope Labeled Compounds Market.

According to the research study conducted by FutureWise research analysts, the Stable Isotope Labeled Compounds Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Stable Isotope Labeled Compounds Market are:

• CAMBRIDGE ISOTOPE LABORATORIES
• MERCK KGAA
• URENCO LIMITED
• ISOSCIENCES
• MEDICAL ISOTOPES
• OMICRON BIOCHEMICALS
• TRACE SCIENCES INTERNATIONAL
• ALSACHIM
• TAIYO NIPPON SANSO CORPORATION
• PERKINELMER
• ROTEM INDUSTRIES ISRAEL
• BOC SCIENCES
• CORTECNET
• ISOFLEX
• HUAYI ISOTOPES CO.
• MESBAH ENERGY CO.
• SHANGHAI RESEARCH INSTITUTE OF CHEMICAL INDUSTRY
• 13C MOLECULAR
• C/D/N ISOTOPES
• SHOKO CO.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Stable Isotope Labeled Compounds Market Segmentation:

By Type

• Deuterium
• Carbon-13
• Oxygen-18
• Nitrogen-15
• Other Stable Isotopes

 By Application

• Research
• Biomedical Research
• Pharmaceutical Research
• Environmental & Ecological Research
• Agricultural Research
• Clinical Diagnostics
• Industrial
• Other Applications

 By End User

• Pharmaceutical and Biotechnology Companies
• Academic & Research Institutes
• Hospitals and Diagnostic Centres
• Other End Users

 By Region

• North America
• Latin America
• Europe
• Asia-Pacific
• Middle East and Africa

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting the market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Stable Isotope Labeled Compounds Market By Type, By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America, and Middle East and Africa
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with the purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
            1.1 Objectives of the Study 
            1.2 Market Definition 
            1.3 Market Scope 
                         1.3.1 Years Considered for the Study
                         1.3.2 Market Covered
            1.4 Currency 
            1.5 Limitations 
            1.6 Stakeholders 
2. Research Methodology 
            2.1 Research Data 
                        2.1.1 Secondary Data
                                   2.1.1.1 Key Data from Secondary Sources
                        2.1.2 Primary Data
                                   2.1.2.1 Key Data from Primary Sources
            2.2 Market Size Estimation 
            2.3 Market Breakdown and Data Triangulation 
            2.4 Assumptions for the Study  
3. Executive Summary
            3.1 Market Outlook
            3.2 Segment Outlook
            3.3 Competitive Insights
4. Global Stable Isotope Labeled Compounds Market Variables, Trends & Scope
            4.1. Market Lineage Outlook
            4.2. Penetration and Growth Prospect Mapping
            4.3. Industry Value Chain Analysis
            4.4. Cost Analysis Breakdown
            4.5. Technology Overview
            4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Market Overview
            5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                                       5.1.1.1. Increasing focus of Biotech Companies Brand Protection
                                        5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                                       5.1.2.1. High Cost Associated with Implementation of CNNs
                  5.1.3. Industry Challenges
                                        5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Stable Isotope Labeled Compounds Market Analysis Tools
             6.1. Industry Analysis - Porter’s
                 6.1.1. Supplier Power
                 6.1.2. Buyer Power
                 6.1.3. Substitution Threat
                 6.1.4. Threat from New Entrants
                 6.1.5. Competitive Rivalry
            6.2. Pestel Analysis
                6.2.1. Political Landscape
                6.2.2. Environmental Landscape
                6.2.3. Social Landscape
                6.2.4. Technology Landscape
                6.2.5. Legal Landscape
           6.3. Major Deals and Strategic Alliances Analysis
                6.3.1. Joint-Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
           6.4. Market Entry Strategies
           6.5. Case Studies
7. Global Stable Isotope Labeled Compounds Market, By Type Historical Analysis and Forecast 2020-2027 (USD Million)
          7.1. Deuterium
          7.2 Carbon-13
          7.3 Oxygen-18
          7.4  Nitrogen-15
          7.5. Other Stable Isotopes
8. Global Stable Isotope Labeled Compounds Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
          8.1. Research
                 8.1.1.Biomedical Research
                 8.1.2.Pharmaceutical Research
                 8.1.3.Environmental & Ecological Research
                 8.1.4.Agricultural Research
          8.2. Clinical Diagnostics
          8.3. Industrial
          8.4. Other Applications
9. Global Stable Isotope Labeled Compounds Market, By Application Historical Analysis and Forecast 2020-2027 (USD Million)
         9.1. Pharmaceutical and Biotechnology Companies
         9.2. Academic & Research Institutes
         9.3. Hospitals and Diagnostic Centres
         9.4. Other End Users
10.  North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million
        10.1. Introduction
        10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
                      10.2.1. U.S.A
                      10.2.2. Canada
                      10.2.3. Mexico
       10.3. Market Size (USD Million) Forecast for North America 2020-2027
11. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       11.1. Introduction
       11.2. Regional Market Trends
       11.3. Historical Market Size (USD Million) Analysis by Country, 2015-2019
                     11.3.1. Brazil
                     11.3.2. Venezuela
                     11.3.3. Argentina
                     11.3.4. Rest of Latin America
       11.4. Market Size (USD Million) Forecast for Latin America 2020-2027
12. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       12.1. Introduction
       12.2. Historical Market Size (USD Million) Analysis by Country, 2015-2019
                     12.2.1. Germany
                     12.2.2. U.K
                     12.2.3. France
                     12.2.4. Italy
                     12.2.5. Spain
                     12.2.6. Russia
                     12.2.7. Poland
                     12.2.8. Switzerland
                     12.2.9. Romania
                     12.2.10. Rest of Western Europe
        12.3. Market Size (USD Million) Forecast for Europe 2020-2027
13. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
       13.1. Introduction
       13.2. Historical Market Size (USD Million) Analysis by Country, 2015-2019
                        13.2.1. Japan
                        13.2.2. China
                        13.2.3. Singapore
                        13.2.4. India
                        13.2.5. Australia and New Zealand
                        13.2.6. ASEAN
                        13.2.7. South Korea
                        13.2.8. Rest of Asia Pacific
        13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
14. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
        14.1. Introduction
        14.2. Historical Market Size (USD Million) Analysis by Country, 2015-2019
                        14.2.1. Saudi Arabia
                        14.2.2. UAE
                        14.2.3. South Africa
                        14.2.4. Egypt
        14.3. Market Size (USD Million) Forecast for MEA 2020-2027
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
        15.1 CAMBRIDGE ISOTOPE LABORATORIES
                       15.1.1 Company Overview
                       15.1.2 Financial Overview
                       15.1.3 Strategic Overview
                       15.1.4 Product Portfolio
                        15.1.5 SWOT Analysis
       15.2 MERCK KGAA
                        15.2.1 Company Overview
                        15.2.2 Financial Overview
                        15.2.3 Strategic Overview
                        15.2.4 Product Portfolio
                        15.2.5 SWOT Analysis  
      15.3 URENCO LIMITED
                        15.3.1 Company Overview
                        15.3.2 Financial Overview
                         15.3.3 Strategic Overview
                         15.3.4 Product Portfolio
                         15.3.5 SWOT Analysis
       15.4. ISOSCIENCES
                          15.4.1 Company Overview
                          15.4.2 Financial Overview
                          15.4.3 Strategic Overview
                          15.4.4 Product Portfolio
                          15.4.5 SWOT Analysis
       15.5. MEDICAL ISOTOPES
                          15.5.1 Company Overview
                          15.5.2 Financial Overview
                          15.5.3 Strategic Overview
                          15.5.4 Product Portfolio
                          15.5.5 SWOT Analysis
       15.6. OMICRON BIOCHEMICALS
                         15.6.1 Company Overview
                         15.6.2 Financial Overview
                         15.6.3 Strategic Overview
                         15.6.4 Product Portfolio
                         15.6.5 SWOT Analysis
       15.7. TRACE SCIENCES INTERNATIONAL
                         15.7.1 Company Overview
                         15.7.2 Financial Overview
                         15.7.3 Strategic Overview
                         15.7.4 Product Portfolio
                         15.7.5 SWOT Analysis
       15.8. ALSACHIM
                         15.8.1 Company Overview
                         15.8.2 Financial Overview
                         15.8.3 Strategic Overview
                         15.8.4 Product Portfolio
                         15.8.5 SWOT Analysis
       15.9. TAIYO NIPPON SANSO CORPORATION
                        15.9.1 Company Overview
                        15.9.2 Financial Overview
                        15.9.3 Strategic Overview
                        15.9.4 Product Portfolio
                        15.9.5 SWOT Analysis
       15.10. PERKINELMER
                      15.10.1 Company Overview
                      15.10.2 Financial Overview
                      15.10.3 Strategic Overview
                      15.10.4 Product Portfolio
                      15.10.5 SWOT Analysis
      15.11. ROTEM INDUSTRIES ISRAEL
                     15.11.1 Company Overview
                     15.11.2 Financial Overview
                     15.11.3 Strategic Overview
                     15.11.4 Product Portfolio
                     15.11.5 SWOT Analysis
      15.12. BOC SCIENCES
                     15.12.1 Company Overview
                     15.12.2 Financial Overview
                     15.12.3 Strategic Overview
                     15.12.4 Product Portfolio
                     15.12.5 SWOT Analysis
      15.13. CORTECNET
                     15.13.1 Company Overview
                     15.13.2 Financial Overview
                     15.13.3 Strategic Overview
                     15.13.4 Product Portfolio
                     15 13.5 SWOT Analysis
       15.14. ISOFLEX
                   15.14.1 Company Overview
                   15.14.2 Financial Overview
                   15.14.3 Strategic Overview
                   15.14.4 Product Portfolio
                   15.14.5 SWOT Analysis
       15.15  HUAYI ISOTOPES CO.
                  15.15.1 Company Overview
                  15.15.2 Financial Overview
                  15.15.3 Strategic Overview
                  15.15.4 Product Portfolio
                  15.15.5 SWOT Analysis
       15.16. MESBAH ENERGY CO.
                  15.16.1 Company Overview
                  15.16.2 Financial Overview
                  15.16.3 Strategic Overview
                  15.16.4 Product Portfolio
                  15.16.5 SWOT Analysis
       15.17 SHANGHAI RESEARCH INSTITUTE OF CHEMICAL INDUSTRY
                  15.17.1 Company Overview
                  15.17.2 Financial Overview
                  15.17.3 Strategic Overview
                  15.17.4 Product Portfolio
                  15.17.5 SWOT Analysis
       15.18 13C MOLECULAR
                  15.18.1 Company Overview
                  15.18.2 Financial Overview
                  15.18.3 Strategic Overview
                  15.18.4 Product Portfolio
                  15.18.5 SWOT Analysis
       15.19 C/D/N ISOTOPES
                 15.19.1 Company Overview
                 15.19.2 Financial Overview
                 15.19.3 Strategic Overview
                 15.19.4 Product Portfolio
                 15.19.5 SWOT Analysis
       15.20 SHOKO CO.
                15.20.1 Company Overview
                15.20.2 Financial Overview
                15.20.3 Strategic Overview
                15.20.4 Product Portfolio
                15.20.5 SWOT Analysis
16. Pre and Post COVID-19 Impact
    16.1. Positive influence on the healthcare industry
    16.2. The financial disruption of the manufacturing sector
    16.3. Impact of COVID-19 on emerging companies
    16.4. Significant mandates in the healthcare regulations initiated by administrations
    16.5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME Key Takeaway Points for Client

Tables

Figures